PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

May 22, 2019

Study Completion Date

May 22, 2019

Conditions
Type1 Diabetes MellitusType 2 Diabetes Mellitus
Interventions
DEVICE

LabPatch Continuous Glucose Monitoring (CGM)

"1. The patch device that will be applied to subjects' arms in this study is about 3 inches in length and one inch in width, with adhesive tape on the sides.~2. The LabPatch circuit chip lies on the underside of the bandage. The circuit is in the form of a small chip (approximately 15.7 mm \[0.618\] x 15.7 mm \[0.618\]) placed in contact with the skin. The chip has a telescopic micropipette which draws interstitial fluid to be analyzed for glucose levels. The chip is also able to measure skin temperature to ensure appropriate skin contact.~3. A wire that connects the chip to a laptop that continuously captures glucose data."

Trial Locations (1)

02215

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
collaborator

Cambridge Medical Technologies, LLC

INDUSTRY

lead

Joslin Diabetes Center

OTHER

NCT03262415 - PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor | Biotech Hunter | Biotech Hunter